XML 31 R11.htm IDEA: XBRL DOCUMENT v3.20.4
Cash, Cash Equivalents, Restricted Cash and Marketable Securities
12 Months Ended
Dec. 31, 2020
Investments Debt And Equity Securities [Abstract]  
Cash, Cash Equivalents, Restricted Cash and Marketable Securities

4.

Cash, Cash Equivalents, Restricted Cash and Marketable Securities

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows:

 

 

 

December 31

 

 

 

2020

 

 

2019

 

 

2018

 

Cash and cash equivalents

 

$

32,073

 

 

$

39,884

 

 

$

49,348

 

Restricted cash

 

 

237

 

 

 

216

 

 

 

619

 

Total cash, cash equivalents and restricted cash shown in the

   consolidated statements of cash flows

 

$

32,310

 

 

$

40,100

 

 

$

49,967

 

Restricted cash balances relate to certificates of deposit issued as collateral to certain letters of credit issued as security to our lease arrangements. See Note 9.

Cash, cash equivalents and marketable securities consist of the following (in thousands):

 

 

 

Amortized

Cost

 

 

Unrealized

Gains

 

 

Unrealized

Losses

 

 

Estimated

Fair Value

 

December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

$

7,945

 

 

$

-

 

 

$

-

 

 

$

7,945

 

Money market funds

 

 

23,128

 

 

 

-

 

 

 

-

 

 

 

23,128

 

Corporate debt securities

 

 

1,000

 

 

 

-

 

 

 

-

 

 

 

1,000

 

Total cash and cash equivalents

 

 

32,073

 

 

 

-

 

 

 

-

 

 

 

32,073

 

Marketable securities available-for-sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. treasuries

 

 

32,548

 

 

 

31

 

 

 

-

 

 

 

32,579

 

U.S. government agency securities

 

 

40,313

 

 

 

14

 

 

 

(6

)

 

 

40,321

 

Corporate debt securities

 

 

60,071

 

 

 

3

 

 

 

(11

)

 

 

60,063

 

Total marketable securities available-for-sale

 

 

132,932

 

 

 

48

 

 

 

(17

)

 

 

132,963

 

Total cash, cash equivalents and marketable securities

 

$

165,005

 

 

$

48

 

 

$

(17

)

 

$

165,036

 

December 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash

 

$

4,038

 

 

$

-

 

 

$

-

 

 

$

4,038

 

Money market funds

 

 

27,854

 

 

 

-

 

 

 

-

 

 

 

27,854

 

Corporate debt securities

 

 

7,992

 

 

 

-

 

 

 

-

 

 

 

7,992

 

Total cash and cash equivalents

 

 

39,884

 

 

 

-

 

 

 

-

 

 

 

39,884

 

Marketable securities available-for-sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. treasuries

 

 

6,511

 

 

 

6

 

 

 

-

 

 

 

6,517

 

U.S. government agency securities

 

 

51,235

 

 

 

50

 

 

 

(12

)

 

 

51,273

 

Corporate debt securities

 

 

53,353

 

 

 

28

 

 

 

-

 

 

 

53,381

 

Total marketable securities available-for-sale

 

 

111,099

 

 

 

84

 

 

 

(12

)

 

 

111,171

 

Total cash, cash equivalents and marketable securities

 

$

150,983

 

 

$

84

 

 

$

(12

)

 

$

151,055

 

 

The maturities of our marketable securities available-for-sale are as follows (in thousands):

 

.

 

December 31, 2020

 

 

 

Amortized

Cost

 

 

Estimated

Fair Value

 

Mature in one year or less

 

$

122,156

 

 

$

122,181

 

Mature after one year through two years

 

 

10,776

 

 

 

10,782

 

 

 

$

132,932

 

 

$

132,963

 

 

For the year ended December 31, 2020, there were gross realized gains on investments of $0.1 million and no gross realized losses. There were no gross realized gains or losses on investments for each of the year ended December 31, 2019 and 2018. Realized gains are included in interest income in the consolidated statements of operations. All investments with unrealized losses at December 31, 2020 have been in a loss position for less than twelve months. We do not intend to sell the investments that are in an unrealized loss position before recovery of their amortized cost basis. To date, there have been no declines in fair value that have been identified as other than temporary.